Strategy Signal conducts empirical research — discovering and developing dynamic metrics for measuring, tracking and forecasting biotech investment and trading opportunities. The objectives of creating a systematic approach to biotech investments/trading are to establish a foundation of common denominators, improve stock selection, and optimize duration. Strategy Signal’s empirical data analyses provide investors with a quantitative lens to view biotech, offering a standardized measurement and selection process so investors can apply systematic principles to biotech stocks.


Strategy Signal offers access to notes published on Coverage Universe companies, periodically published Biotech Outlook notes, and future access to its larger Strategy Signal Quant Models Coverage Universe, plus Analyst access. 


Contact your Analyst Hub sales person ( to discuss pricing and access to Strategy Signal’s proprietary Next-Gen Biotech research.